| Groups | Dose (µg/ml) | Survival (%) |
| N | — | 100 ± 2.80 |
| AS | 0.1 | 105.94 ± 7.10 |
| 1 | 102.98 ± 4.94 | |
| 10 | 112.54 ± 7.02 | |
| HT | 0.1 | 114.38 ± 9.32 |
| 1 | 102.16 ± 4.31 | |
| 10 | 100.63 ± 4.26 | |
| CA | 0.1 | 116.18 ± 3.65 |
| 1 | 103.76 ± 4.22 | |
| 10 | 106.33 ± 4.70 | |
| JQ | 0.1 | 101.89 ± 5.09 |
| 1 | 108.34 ± 3.56 | |
| 10 | 102.87 ± 3.01 | |
| LA | 0.1 | 106.13 ± 4.06 |
| 1 | 101.16 ± 6.38 | |
| 10 | 101.48 ± 4.58 |